Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,251 | -22,942 | -20,997 | -23,283 | -22,447 |
| Depreciation Amortization | 955 | 1,048 | 1,109 | 1,031 | 1,014 |
| Accounts payable and accrued liabilities | -419 | -103 | -321 | 588 | -329 |
| Other Working Capital | -215 | 1,667 | -4,789 | 1,535 | -509 |
| Other Operating Activity | 8,045 | 5,052 | 5,842 | 4,906 | 4,903 |
| Operating Cash Flow | $-15,885 | $-15,278 | $-19,156 | $-15,223 | $-17,368 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,208 | 13,460 | 5,769 | 17,030 | -40,661 |
| PPE Investments | N/A | -218 | -892 | -260 | -6 |
| Investing Cash Flow | $9,208 | $13,242 | $4,877 | $16,770 | $-40,667 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5 | -7 | -20 | -30 | -55 |
| Common Stock Issued | 9,179 | N/A | 99 | 6,995 | 48,102 |
| Financing Cash Flow | $9,174 | $-7 | $79 | $6,965 | $48,047 |
| Beginning Cash Position | 5,037 | 7,080 | 21,280 | 12,768 | 22,756 |
| End Cash Position | 7,534 | 5,037 | 7,080 | 21,280 | 12,769 |
| Net Cash Flow | $2,497 | $-2,043 | $-14,200 | $8,512 | $-9,988 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,885 | -15,278 | -19,156 | -15,223 | -17,368 |
| Capital Expenditure | N/A | -218 | -892 | -260 | -6 |
| Free Cash Flow | -15,885 | -15,496 | -20,048 | -15,483 | -17,374 |